ウィスコンシンにおける非ホジキンリンパ腫の臨床試験
ウィスコンシン内の拠点で、非ホジキンリンパ腫に関する20件の研究が参加者を募集しています。
ウィスコンシン内の都市
公式研究テキスト（英語）
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital of Wisconsin, Milwaukee
被験者募集中観察研究
0歳〜38歳 · 全性別 · 2026/10/01更新 · NCT06131801A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07101328TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Aurora Cancer Care - Burlington, Burlington
- Aurora Health Care - Germantown Health Center, Germantown
- Aurora Cancer Care - Grafton, Grafton
- 他13件
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- University of Wisconsin Carbone Cancer Center, Madison
被験者募集中第1相
18歳〜100歳 · 全性別 · 2026/09/15更新 · NCT05798897Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, Milwaukee
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06526793Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/08更新 · NCT03666000Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Medical College of Wisconsin, Milwaukee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT05826535LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
- Froedtert & the Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳〜81歳 · 全性別 · 2026/08/06更新 · NCT05990465Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/05更新 · NCT06116110DALY II USA/ MB-CART2019.1 for DLBCL
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/13更新 · NCT04792489A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Wisconsin - Madison, Madison
- Children's Hospital of Wisconsin, Milwaukee
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Aspirus Langlade Hospital, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Ascension Saint Elizabeth Hospital, Appleton
- 他61件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
- Medical College of Wisconsin, Milwaukee
被験者募集中第4相
18歳以上 · 全性別 · 2026/03/02更新 · NCT06876662A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- Medical College of Wisconsin, Milwaukee
被験者募集中第4相
18歳以上 · 全性別 · 2026/03/02更新 · NCT06876649CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2026/02/23更新 · NCT04186520Study of SGR-1505 in Mature B-Cell Neoplasms
- Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT05544019AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- The Medical College of Wisconsin, Milwaukee
被験者募集中第1相
18歳以上 · 全性別 · 2025/12/10更新 · NCT05602363SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- University of Wisconsin Carbone Cancer Center, Madison
被験者募集中第1相
7 Months – 21 Years · 全性別 · 2025/10/16更新 · NCT02508038ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。